Various studies have been conducted to evaluate the impact of adjuvant chemotherapy on survival outcomes in elderly patients with stage III colon cancer. Studies have also looked at the effectiveness of different chemotherapy regimens and the role of molecular markers in predicting treatment efficacy and patient outcomes.